Patents Assigned to University of Texas Systems
  • Patent number: 11825847
    Abstract: Disclosed herein are methods of making pure chalcogenide (e.g., selenium, tellurium, or selenium/tellurium) nanoparticles by irradiating chalcogenide pellets by nano-second laser ablation using chitosan as a capping agent to form chitosan chalcogenide nanoparticles (CS-CgNPs). CS-CgNPs and methods of using such particles are also disclosed herein, such as antimicrobials and antimicrobial coatings effective against biofilms.
    Type: Grant
    Filed: August 2, 2021
    Date of Patent: November 28, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Kelly Nash, Gregory Guisbiers, Humberto Herman Lara Villegas
  • Patent number: 11827851
    Abstract: Tracer eluting proppants, such as proppants that have polymeric coatings on them that include tracers, such as a fluorescent dye. The tracer eluting proppants can comprise proppant particles coated with a polymeric coating that can elute tracer under some, but not all conditions. For example, the tracer can be eluted at elevated temperature, pH, and/or salinity conditions, but not elute at lower temperature, pH, and/or salinity conditions. Methods of making and using tracer eluting proppants are also disclosed, including methods for characterizing subterranean reservoirs.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: November 28, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Kishore K. Mohanty, Bochao Zhao, Krishna Panthi, Robin Singh
  • Patent number: 11826422
    Abstract: Embodiments are directed to methods and compositions for modulating an immune response. In certain aspects the immune response is a type I hypersensitivity response. In particular aspects the subject has allergic asthma or allergic rhinitis. Using a conventional experimental asthma mouse model (BALB/c), the inventors demonstrate that aerosol administration of TLR agonists, in particular a combination of TLR2/6 and TLR9 agonist (e.g., TLR9 oligonucleotide agonist/PAM2CSK4) along with an antigen (e.g., ovalbumin (OVA)) suppresses the immune response as exemplified by the production of antigen-specific IgE and decreases the number of airway eosinophils in bronchoalveolar lavage fluid (BAL) in response to intraperitoneal (IP) immunization with an antigen mixed with alum.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: November 28, 2023
    Assignee: Board of Regents, the University of Texas System
    Inventors: Burton F. Dickey, Michael J. Tuvim, Scott E. Evans, Magnus Hook, David P. Huston, Margarita Martinez-Moczygemba, Brenton Scott
  • Publication number: 20230374126
    Abstract: Antibody antigen binding domains which specifically binds human leptin comprises VH or VL CDR1, CDR2 and CDR3 sequences of an hLept antibody. The antibody antigen binding domains and antibodies thereof are useful to treat obesity and diabetes.
    Type: Application
    Filed: August 4, 2023
    Publication date: November 23, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Zhiqiang An, Ningyan Zhang, Philipp E. Scherer, Shangang Zhao
  • Publication number: 20230374138
    Abstract: Chemotherapy-induced peripheral neuropathy (CIPN) is a primary dose-limiting side effect caused by antineoplastic agents, such as paclitaxel. This causes damage to peripheral nerves and the dorsal root ganglia (DRG). Currently, there are no effective treatments for CIPN, which can lead to long-term morbidity in patients and survivors. Neuronal-immune interactions occur in CIPN and have been implicated both in the development and progression of the disease and disease resolution. The inventors investigated the potential role of Inducible co-stimulatory molecule (ICOS) in the resolution of CIPN. ICOS is an immune checkpoint molecule that is expressed on the surface of activated T cells and promotes proliferation and differentiation of T cells. They found that intrathecal administration of ICOS agonist antibody (ICOSaa) alleviates mechanical hypersensitivity caused by paclitaxel and facilitates the resolution of pain in female mice without a clear benefit in male mice.
    Type: Application
    Filed: April 24, 2023
    Publication date: November 23, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Theodore J. Price, Ishwarya Sankaranarayanan
  • Publication number: 20230372468
    Abstract: The current disclosure provides compositions and methods for treatment and prevention of a coronavirus infection. Certain aspects are directed to lipid vesicles comprising SARS-CoV-2 spike protein or a portion or variant thereof. Further aspects include methods for treatment or prevention of a coronavirus infection comprising providing a lipid vesicle comprising a therapeutic protein, such as SARS-CoV-2 spike protein or ACE2. In some embodiments, the disclosed lipid vesicles are useful for targeted delivery of anti-viral therapeutic agents.
    Type: Application
    Filed: March 23, 2021
    Publication date: November 23, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventor: RAGHU KALLURI
  • Publication number: 20230375541
    Abstract: Ultra near-field index modulated plasmonic nano-aperture label-free imaging methods and techniques are useful for imaging and detection of biological microparticles and nanoparticles such as circulating tumor exosomes (CTEs), bacteria and vimses. The methods and techniques utilize a high-density array of gold, silver, or gold/silver alloy nanodisks, in some cases on an undercut or invisible substrate. Given the relatively large nanodisk dimensions, the nanodisk array may feature a significantly blue-shifted LSPR extinction peak due to both far-field plasmonic coupling and substrate undercut. The ultra near-field imaging methods have the ability to image nanoparticles as small as 25 nm.
    Type: Application
    Filed: October 4, 2021
    Publication date: November 23, 2023
    Applicants: University of Houston System, Board of Regents, The University of Texas System
    Inventors: Wei-Chuan Shih, Nareg Ohannesian, Steven H. Lin
  • Patent number: 11823392
    Abstract: A method, system and computer program product for segmenting generic foreground objects in images and videos. For segmenting generic foreground objects in videos, an appearance stream of an image in a video frame is processed using a first deep neural network. Furthermore, a motion stream of an optical flow image in the video frame is processed using a second deep neural network. The appearance and motion streams are then joined to combine complementary appearance and motion information to perform segmentation of generic objects in the video frame. Generic foreground objects are segmented in images by training a convolutional deep neural network to estimate a likelihood that a pixel in an image belongs to a foreground object. After receiving the image, the likelihood that the pixel in the image is part of the foreground object as opposed to background is then determined using the trained convolutional deep neural network.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: November 21, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Kristen Grauman, Suyog Dutt Jain, Bo Xiong
  • Patent number: 11819826
    Abstract: A dimeric ionic liquid that enhances and improves the performance and durability of a fuel cell catalyst. The dimeric ionic liquid comprises 1,1-(butane-1, 4-diyl)bis(9-methyl-3,4,6,7,8,9-hexahydro-2H-pyrimido[1,2-a]pyrimidin-1-ium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate. Membrane electrode assemblies (MEAs) and polymer electrolyte membrane fuel cells (PEMFCs) employing the dimeric ionic liquid are also disclosed.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: November 21, 2023
    Assignees: Toyota Motor Engineering & Manufacturing North America, Inc., Board of Regents, The University of Texas System
    Inventors: Liang Wang, Hongfei Jia, Joan F. Brennecke, Oscar Morales Collazo, Hisao Kato
  • Publication number: 20230365708
    Abstract: The present disclosure is directed to dual specific antibodies, which bind to both PD-L1 and PD-L2, and methods of using such antibodies to treat cancers, such as those that express or overexpress PD-L1, PD-L2, or both.
    Type: Application
    Filed: March 31, 2023
    Publication date: November 16, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventor: Michael CURRAN
  • Publication number: 20230366033
    Abstract: Provided herein are methods for selecting and treating cancers that are homology-directed repair (HDR) proficient. As such, methods for sensitizing cancers to PARP inhibitor therapy and ionizing radiation are also provided. In some aspects, cancers are treated with a combination of a GRB2 inhibitor and a PARP inhibitor or a GRB2 inhibitor and ionizing radiation.
    Type: Application
    Filed: August 3, 2021
    Publication date: November 16, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: John A. TAINER, Zamal AHMED, Zu YE
  • Publication number: 20230357960
    Abstract: A quad-polymer composition includes monomers of (a) acrylonitrile, (a) vinylimidazole, (c) methyl acrylate and (d) either acrylic acid or itaconic acid. Such quad-polymer compositions may be used to form fibers (such as by melt spinning) that may then be annealed, stabilized, and/or carbonized to produce carbon fibers. The quad-polymer composition may be used for supercapacitors, lithium battery electrodes once carbonized, and as synthesized, it may be used for wound healing fibers, fabrics, coatings, and films, and anti-bacterial/anti-microbial fibers, fabrics, coatings and films. The carbon fibers formed from the quad-polymer composition may be used for the fiber composites for automobile, aerospace structures, marine structures, military equipment/parts, sporting goods, robotics, furniture, and electronic parts.
    Type: Application
    Filed: July 3, 2023
    Publication date: November 9, 2023
    Applicants: Board of Regents, The University of Texas System, Korea Institute of Carbon Convergence Technology
    Inventors: Min Hye Jung, Hyun Kyu Shin, Kyu Soon Park, Duck Joo Yang, Benjamin Batchelor, Samsuddin Mahmood
  • Publication number: 20230357959
    Abstract: A quad-polymer composition includes monomers of (a) acrylonitrile, (a) vinylimidazole, (c) methyl acrylate and (d) either acrylic acid or itaconic acid. Such quad- polymer compositions may be used to form fibers (such as by melt spinning) that may then be annealed, stabilized, and/or carbonized to produce carbon fibers. The quad-polymer composition may be used for supercapacitors, lithium battery electrodes once carbonized, and as synthesized, it may be used for wound healing fibers, fabrics, coatings, and films, and anti-bacterial/anti-microbial fibers, fabrics, coatings and films. The carbon fibers formed from the quad-polymer composition may be used for the fiber composites for automobile, aerospace structures, marine structures, military equipment/parts, sporting goods, robotics, furniture, and electronic parts.
    Type: Application
    Filed: July 3, 2023
    Publication date: November 9, 2023
    Applicants: Board of Regents, The University of Texas System, Korea Institute of Carbon Convergence Technology
    Inventors: Min Hye Jung, Hyun Kyu Shin, Kyu Soon Park, Duck Joo Yang, Benjamin Batchelor, Samsuddin Mahmood
  • Publication number: 20230346781
    Abstract: The present disclosure provides compounds, their pharmaceutical compositions, and methods of their use for treating mesenchymally-derived or mesenchymally-transformed cancers, such as breast cancers and sarcomas, and for treating diseases or disorders that are characterized by the expression of vimentin.
    Type: Application
    Filed: July 11, 2023
    Publication date: November 2, 2023
    Applicants: The Scripps Research Institute, Board of Regents, The University of Texas System
    Inventors: Luke L. LAIRSON, Michael J. BOLLONG, Peter G. SCHULTZ, Sendurai A. Mani
  • Patent number: 11802272
    Abstract: Methods of, treatments using, and devices for restoring the regenerative capability for mesenchymal stem cells and isolating and expanding a small subpopulation of less defective mesenchymal stem cells from the bone marrow stromal cells of people with decreased quality and/or quantity of mesenchymal stem cells, such as elderly people.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: October 31, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Travis Block, Milos Marinkovic, Xiao-dong Chen
  • Publication number: 20230342524
    Abstract: Systems and methods for simulating subterranean regions having fracture geometries. Non-intrusive embedded discrete fracture modeling formulations are applied to two-dimensional and three-dimensional unstructured grids, with mixed elements, using an element-based finite-volume method in conjunction with commercial simulators to model subsurface characteristics in regions having complex hydraulic fractures, complex natural fractures, or a combination of both.
    Type: Application
    Filed: May 23, 2023
    Publication date: October 26, 2023
    Applicants: Sim Tech LLC, Board of Regents, The University of Texas System
    Inventors: Kamy Sepehrnoori, Yifei Xu, Wei Yu, Francisco Marcondes, Jijun Miao
  • Patent number: 11794175
    Abstract: A metal-free porphyrin based crystalline 2D organic polymer obtained from the condensation of terephthaloyl chloride and 5,10,15,20-tetrakis(4-aminophenyl porphyrin, namely H2TAPP), which is an effective bifunctional electrocatalyst for the oxygen evolution reaction (OER) in basic conditions and the hydrogen evolution reaction (HER) in neutral solutions. The electrochemical response of this material is explored under oxidation and reduction conditions in order to study its catalytic activity, charge transfer and stability.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: October 24, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Dino Villagran, Yulu Ge
  • Patent number: 11795512
    Abstract: The present disclosure provides methods and compositions for the detection of bladder in a subject using four locus-specific probes to 6p22, 8q22, 11q13, and 20p11.2.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: October 24, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Bogdan Czerniak, Keith Baggerly, Jolanta Bondaruk, Tadeusz Majewski, Colin Dinney, Shizhen Zhang, Yan Wang
  • Patent number: 11794040
    Abstract: Apparatuses and methods for generating therapeutic shock waves. Some embodiments comprise: an acoustic-wave generator configured to emit acoustic waves having at least one frequency between 1 MHz and 1000 MHz; a shock wave housing coupled to the acoustic-wave generator; and a shock wave medium disposed in the shock wave housing; where the apparatus is configured such that if the acoustic-wave generator emits acoustic waves then at least some portion of the acoustic waves will travel through the shock wave medium and form one or more shock waves.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: October 24, 2023
    Assignee: The Board of Regents of the University of Texas System
    Inventor: Christopher C. Capelli
  • Patent number: 11795457
    Abstract: Described are compounds and methods useful for the treatment and investigation of Friedreich's Ataxia.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: October 24, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: David Corey, Liande Li